Reviewing Last Week's Success:

Last week was more than solid in terms of how we fared with our options trading ideas. After a big time week wherein we unearthed multiple thousand-percent or better gains, we closed things out with a bang on Friday by going two for three on on the fresh ideas we had signaled. 

Our targets, the NKE Weekly $155-152.50 Puts and the COST Weekly $452.50-457.50 Calls both produced some really nice intraday gain opportunities for ourselves and our readers, and put a nice cap on one heck of a trading week.

NKE Weekly $155-152.50 Puts
 3.75-7.05 (+88%)
$152.50: 2.37-4.48 (+89%)

COST Weekly $452.50-457.50 Calls
 4.74-16.00 (+238%)
$455: 3.05-13.64 (+347%)
$457.50: 5.00-10.22 (+104%)

Fresh Options Ideas: 
CDZI 11/19 $7.50 Calls 
HYFM 11/19 $35-40 Calls 


Trans Global Group, Inc. TGGI - More New Highs:

We were just reporting back to our readers Friday morning on a OTC play we've been tracking in our reports repeatedly since initially flagging it on Aug. 12th.

We first caught TGGI at a low of .003, and after yet another mammoth session on Friday, it soared to a new high of .0267. That works out to an amazing run of 790% over the past six weeks or so and it has been very entertaining to watch.

Extended Watchlist:

View this email in your browser
Twitter Twitter
Facebook Facebook
Website Website
LinkedIn LinkedIn
YouTube YouTube
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Our disclaimer is to be read and fully agreed to before using our site, or joining our email list. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions, however any that may occur will be corrected as needed. BHS and its affiliates are not registered or licensed investment advisers, nor broker dealers. BHS cautions that the investments in companies profiled are commonly considered to be extremely high risk and use of any information provided is at the investor's sole risk.
Copyright © 2021, All rights reserved.

No longer want to receive our emails? You may unsubscribe from this list at any time.